Posted by AGORACOM-JC
at 11:38 AM on Tuesday, October 24th, 2017
WHY TETRA BIO-PHARMA?
Only pharmaceutical company to have clinical studies for smoked marijuana;
Signed a letter of intent with a major player of the healthcare specialty industry
Will benefit from the intellectual property created within the cannabis health research Chair from the University of New Brunswick
Company is financially sound, with enough cash to pay for the $1.2Â million Phase III clinical trials of PPP001.
Filing a clinical trial application in the coming weeks to therapeutic products directorate to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patient
Focused on expanding commercialization partnerships internationally for product pipeline – Interest has been shown from the USA, Germany, Ireland, Brazil and Mexico;
Initial demand forecasted in New Brunswick for PPP001 using the ACMPR license is more than expected
betterU Partners With Adobe to Deliver Leading Digital Experience Programs in India
Capitalizing On Mobile Payments Structure Others Unable To Provide
Unique Ability To Collect From 200 Different Payment Methods in India
As A Result, Leading Global Online Education Providers Use BetterU
BetterU Receives 20 – 50% Of All Revenues Generated
Indian Government Mandate To Educate 500 million by 2022
India Expecting To Double Online Education From $20B to $40B
Executed MOU with the Telecom Sector Skill Council to jointly support both organizations’ efforts towards the skilling of millions of professionals across India’s Telecom sector
Posted by AGORACOM-JC
at 1:04 PM on Wednesday, October 18th, 2017
PyroGenesis Canada Inc. (TSX-V: PYR) (OTC: PYRNF) (Frankfurt: 8PYF)
Arguably the most advanced plasma technology Company in the world, with one of the largest concentration of plasma expertise under one roof working out of a ~40,000 sq. ft. facility in Montreal,
Considered the go-to source for the US Military when an application requires a plasma solution, it has over 57 patents (issued or pending), including being the inventors of ‘plasma atomization’ which is considered the current gold standard for production of Titanium-metal powder used in additive manufacturing (3D printers).
Company’s latest innovations/plasma solutions in chemical warfare agent destruction, metallurgy, and especially additive manufacturing, are all revolutionary, each on the cusp of exponential growth, and position the share price of PYR.V at a major inflection point, presenting opportunity for astute shareholders.
Posted by AGORACOM-JC
at 1:28 PM on Tuesday, October 17th, 2017
Augusta Industries (AAO:TSXV) is a superstar company that very few people small cap investors have ever heard of. More than just lip service, take a quick look at the client rolls of their 2 subsidiaries. Once you do, you’ll understand why Augusta just announced a spin out transaction that will split the subsidiaries into two companies, making shareholders very happy.
SUBSIDIARIES
1]  FOX-TEK – World leading solutions to various sectors including the oil and gas industry. With non- intrusive technologies including: fiber optic sensors and electric field mapping systems; FOX-TEK is able to accurately measure changes that could negatively impact clients’ operations, the list of which includes the following Tier-1 Energy Companies.
2]  Marcon International – an industrial supply contractor servicing the energy sector and a number of US Government entities. Marcon’s principal business is the sale and distribution of industrial parts and equipment to clients that include government departments and global energy companies.
Aiming to deliver $25M in additional shareholder value with its Sensor Technologies spin out announcement on September 28th.
At the time of “Spin outâ€, Augusta will own 50 Million shares of Sensor Tech, and 100% of Marcon International,
Transaction unleashing the potential for explosive growth through its multinational relationships and state of the art monitoring technology
Augusta is a burgeoning beast in the Oil & Gas service sector with its multi-faceted approach to creating shareholder value for its shareholders.
